Large deletion in 6q associated to A20 haploinsufficiency and thoracoabdominal heterotaxy
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
---|---|
Enthalten in: |
Annals of the rheumatic diseases - 77(2018), 11 vom: 22. Nov., Seite 1697-1698 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Viel, Sébastien [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 03.09.2019 Date Revised 03.09.2019 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/annrheumdis-2018-213300 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM283268972 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM283268972 | ||
003 | DE-627 | ||
005 | 20231225040232.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/annrheumdis-2018-213300 |2 doi | |
028 | 5 | 2 | |a pubmed24n0944.xml |
035 | |a (DE-627)NLM283268972 | ||
035 | |a (NLM)29678940 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Viel, Sébastien |e verfasserin |4 aut | |
245 | 1 | 0 | |a Large deletion in 6q associated to A20 haploinsufficiency and thoracoabdominal heterotaxy |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.09.2019 | ||
500 | |a Date Revised 03.09.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Letter | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a fever syndromes | |
650 | 4 | |a gene polymorphism | |
650 | 4 | |a inflammation | |
650 | 7 | |a CITED2 protein, human |2 NLM | |
650 | 7 | |a Repressor Proteins |2 NLM | |
650 | 7 | |a Trans-Activators |2 NLM | |
650 | 7 | |a TNFAIP3 protein, human |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor alpha-Induced Protein 3 |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
700 | 1 | |a Cheyssac, Elodie |e verfasserin |4 aut | |
700 | 1 | |a Pescarmona, Rémi |e verfasserin |4 aut | |
700 | 1 | |a Besson, Laurie |e verfasserin |4 aut | |
700 | 1 | |a Till, Marianne |e verfasserin |4 aut | |
700 | 1 | |a Viremouneix, Loïc |e verfasserin |4 aut | |
700 | 1 | |a Touitou, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Sarrabay, Guillaume |e verfasserin |4 aut | |
700 | 1 | |a Walzer, Thierry |e verfasserin |4 aut | |
700 | 1 | |a Belot, Alexandre |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 77(2018), 11 vom: 22. Nov., Seite 1697-1698 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
773 | 1 | 8 | |g volume:77 |g year:2018 |g number:11 |g day:22 |g month:11 |g pages:1697-1698 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/annrheumdis-2018-213300 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 77 |j 2018 |e 11 |b 22 |c 11 |h 1697-1698 |